Investor Rosalind Advisors, Inc.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Rosalind Advisors, Inc. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-08-13 13G/A PYPD / PolyPid Ltd. 4,081,088 5,762,349
2025-08-13 13G/A US49721T1016 / KIORA PHARMACEUTICALS INC 715,231 464,676
2025-08-12 13G/A 570,326
2025-08-11 13G/A OPTN / OptiNose, Inc. 343,781 0
2025-08-11 13G/A MYO / Myomo, Inc. 7,279,046 7,359,046
2025-08-11 13G/A NSPR / InspireMD, Inc. 9,713,171 10,987,104
2025-08-11 13G/A BFRI / Biofrontera Inc. 9,886,969 14,432,072
2025-08-11 13G/A NSPR / InspireMD, Inc. 9,713,171 10,987,104
2025-08-11 13G/A NSPR / InspireMD, Inc. 9,713,171 10,987,104
2025-05-13 13G/A BFRI / Biofrontera Inc. 9,962,649 9,886,969
2025-05-12 13G/A 670,158
2025-05-12 13G/A OPTN / OptiNose, Inc. 964,587 343,781
2025-05-12 13G/A NSPR / InspireMD, Inc. 9,933,964 9,713,171
2025-05-12 13G/A MYO / Myomo, Inc. 7,574,330 7,279,046
2025-05-12 13D/A DCTH / Delcath Systems, Inc. 6,659,993 6,674,993
2025-04-11 13G TLPH / Talphera, Inc. 7,642,515
2025-02-14 13G/A PYPD / PolyPid Ltd. 4,081,088
2025-02-13 13G/A TRVI / Trevi Therapeutics, Inc. 750,000 1,062,500
2025-02-13 13G/A SPRB / Spruce Biosciences, Inc. 0 0
2025-02-12 13G/A BFRI / Biofrontera Inc. 426,002 9,962,649
2025-02-11 13G/A 628,050 791,315
2025-02-10 13G/A PYPD / PolyPid Ltd. 679,168 4,085,588
2025-02-10 13G/A US49721T1016 / KIORA PHARMACEUTICALS INC 2,300,000 715,231
2025-02-07 13G/A OPTN / OptiNose, Inc. 964,587
2025-02-07 13G/A NSPR / InspireMD, Inc. 2,514,046 9,933,964
2025-02-04 13G/A MYO / Myomo, Inc. 3,021,391 7,574,330
2025-02-03 13G/A CLRB / Cellectar Biosciences, Inc. 3,671,550 7,472,745
2025-01-27 13D/A DCTH / Delcath Systems, Inc. 2,763,468 6,659,993
2024-12-02 13D NRXS / NeurAxis, Inc. 2,100,840
2024-12-02 13G NRXS / NeurAxis, Inc. 2,100,840
2024-11-14 13D/A DCTH / Delcath Systems, Inc. 2,763,468 2,763,468
2024-11-14 13D/A DCTH / Delcath Systems, Inc. 2,763,468 2,763,468
2024-11-06 13G/A BFRI / Biofrontera Inc. 495,490 426,002
2024-10-28 13G/A NSPR / InspireMD, Inc. 2,513,641 2,514,046
2024-10-23 13G/A BFRI / Biofrontera Inc. 504,261 495,490
2024-10-23 13G/A PYPD / PolyPid Ltd. 679,688 679,168
2024-10-23 13G/A MDWD / MediWound Ltd. 513,490 628,050
2024-10-23 13G/A TRVI / Trevi Therapeutics, Inc. 1,391,577 750,000
2024-10-23 13G/A SPRB / Spruce Biosciences, Inc. 1,508,419 0
2024-10-18 13G/A OPTN / OptiNose, Inc. 7,547,148 8,287,503
2024-10-18 13G/A MYO / Myomo, Inc. 2,664,999 3,021,391
2024-08-14 13G/A PYPD / PolyPid Ltd. 415,800 679,688
2024-08-14 13G/A CLRB / Cellectar Biosciences, Inc. 2,709,516 3,671,550
2024-07-11 13G/A MYO / Myomo, Inc. 2,447,740 2,664,999
2024-07-11 13G/A MYO / Myomo, Inc. 2,447,740 2,664,999
2024-07-11 13G/A TRVI / Trevi Therapeutics, Inc. 926,016 1,391,577
2024-07-11 13G/A NSPR / InspireMD, Inc. 2,492,765 2,513,641
2024-07-11 13G/A MDWD / MediWound Ltd. 485,990 513,490
2024-07-11 13G/A CLRB / Cellectar Biosciences, Inc. 3,305,936 2,709,516
2024-05-29 13G US49721T1016 / KIORA PHARMACEUTICALS INC 2,300,000
2024-05-29 13G/A OPTN / OptiNose, Inc. 4,541,489 7,547,148
2024-05-29 13G US49721T1016 / KIORA PHARMACEUTICALS INC 2,300,000
2024-05-29 13G/A BFRI / Biofrontera Inc. 504,261 504,261
2024-05-17 13G/A NSPR / InspireMD, Inc. 1,371,126 2,492,765
2024-05-17 13D/A DCTH / Delcath Systems, Inc. 1,151,907 2,763,468
2024-04-25 13G/A CLRB / Cellectar Biosciences, Inc. 1,488,400 3,305,936
2024-04-25 13G/A TRVI / Trevi Therapeutics, Inc. 2,499,993 926,016
2024-04-25 13G/A NSPR / InspireMD, Inc. 989,940 1,371,126
2024-04-25 13G/A MDWD / MediWound Ltd. 479,990 485,990
2024-04-25 13G/A MYO / Myomo, Inc. 2,433,740 2,447,740
2024-04-25 13G/A OPTN / OptiNose, Inc. 4,885,580 4,541,489
2024-04-25 13G/A SPRB / Spruce Biosciences, Inc. 2,322,000 1,508,419
2024-03-25 13D/A DCTH / Delcath Systems, Inc. 1,098,143 1,151,907
2024-03-20 13G BFRI / Biofrontera Inc. 504,261 504,261
2024-03-20 13G BFRI / Biofrontera Inc. 504,261
2024-03-01 13G PYPD / PolyPid Ltd. 415,800
2024-02-22 13G/A OPTN / OptiNose, Inc. 6,435,000 4,885,580
2024-02-20 13G/A GTHP / Guided Therapeutics, Inc. 2,338,740 0
2024-02-20 13G/A SIENQ / Sientra, Inc. 509,274 0
2024-02-14 13G/A MYO / Myomo, Inc. 2,661,418 2,433,740
2024-02-14 13G/A MYO / Myomo, Inc. 2,661,418 2,433,740
2024-02-14 13G/A NSPR / InspireMD, Inc. 989,940
2024-02-14 13G/A MDWD / MediWound Ltd. 444,326 479,990
2024-02-14 13G/A MDWD / MediWound Ltd. 444,326 479,990
2024-02-14 13G/A CLRB / Cellectar Biosciences, Inc. 986,293 1,488,400
2024-01-30 13G SPRB / Spruce Biosciences, Inc. 2,322,000
2023-11-28 13D/A DCTH / Delcath Systems, Inc. 701,500 1,098,143
2023-08-28 13G/A MYO / Myomo, Inc. 553,290 2,661,418
2023-07-28 13G OPTN / OptiNose, Inc. 6,435,000 6,435,000
2023-06-08 13G NSPR / InspireMD, Inc. 1,860,405
2023-02-15 13G SIENQ / Sientra, Inc. 509,274
2023-02-15 13G TRVI / Trevi Therapeutics, Inc. 2,185,664 2,499,993
2023-02-14 13G/A CLRB / Cellectar Biosciences, Inc. 605,228 986,293
2022-12-21 13G MDWD / MediWound Ltd. 444,326
2022-12-21 13D/A DCTH / Delcath Systems, Inc. 701,500 701,500
2022-11-03 13G/A CLRB / Cellectar Biosciences, Inc. 6,052,282 605,228
2022-07-21 13D/A DCTH / Delcath Systems, Inc. 423,500 701,500
2022-07-06 13G GTHP / Guided Therapeutics, Inc. 2,338,740
2022-03-09 13G TRVI / Trevi Therapeutics, Inc. 2,185,664
2022-03-09 13D/A DCTH / Delcath Systems, Inc. 406,500 423,500
2022-02-14 13D/A DCTH / Delcath Systems, Inc. 406,500 406,500
2022-02-14 13G/A PHAS / PhaseBio Pharmaceuticals Inc 2,607,857 707,467
2022-02-14 13G/A PLXP / PLx Pharma Inc. 970,425 0
2022-02-11 13G GRTX / Galera Therapeutics, Inc. 1,543,783
2022-01-21 13G/A CLRB / Cellectar Biosciences, Inc. 3,207,160 6,052,282
2022-01-20 13G/A UNCY / Unicycive Therapeutics, Inc. 812,555 969,484
2022-01-20 13G/A MYO / Myomo, Inc. 365,900 553,290
2022-01-07 13G ATXS / Astria Therapeutics, Inc. 653,438
2021-09-23 13G UNCY / Unicycive Therapeutics, Inc. 812,555
2021-07-08 13G CLRB / Cellectar Biosciences, Inc. 3,207,160
2021-06-25 13D/A DCTH / Delcath Systems, Inc. 406,500 406,500
2021-05-19 13G PHAS / PhaseBio Pharmaceuticals Inc 2,607,857
2021-05-19 13G MYO / Myomo, Inc. 365,900
2021-04-06 13D/A DCTH / Delcath Systems, Inc. 701,500 406,500
2021-01-22 13G/A PLXP / PLx Pharma Inc. 970,425 970,425
2021-01-22 13G/A VTGN / Vistagen Therapeutics, Inc. 4,000,000 5,377,113
2020-12-18 13G PLXP / PLx Pharma Inc. 970,425
2020-09-18 13G VTGN / Vistagen Therapeutics, Inc. 4,000,000
2020-05-14 13D/A DCTH / Delcath Systems, Inc. 853,950 701,500
2020-04-10 13D/A DCTH / Delcath Systems, Inc. 853,950 853,950
2020-04-09 13D/A DCTH / Delcath Systems, Inc. 853,950 853,950
2020-03-12 13D DCTH / Delcath Systems, Inc. 853,950 853,950
2020-03-11 13D DCTH / Delcath Systems, Inc. 853,950 853,950
2020-03-06 13G/A DCTH / Delcath Systems, Inc. 468,452 853,950
2020-02-13 13G/A DCTH / Delcath Systems, Inc. 280,000,000 468,452
2019-08-01 13G DCTH / Delcath Systems, Inc. 280,000,000
2019-07-24 13G/A US16706W1027 / Chiasma Inc 2,003,478 936,651
2019-02-15 13G/A US16706W1027 / Chiasma Inc 2,003,478 2,003,478
2019-02-15 13G/A H03579101 / Auris Medical Holding Ltd 420,000 420,000
2019-02-14 13G/A TNXP / Tonix Pharmaceuticals Holding Corp. 594,077 40,169
2019-02-14 13G/A 76028H209 / Repros Therapeutics, Inc. 3,332,292 0
2019-02-14 13G/A US16706W1027 / Chiasma Inc 1,459,100 2,003,478
2019-02-14 13G/A H03579101 / Auris Medical Holding Ltd 2,050,489 420,000
2018-11-23 13G US16706W1027 / Chiasma Inc 1,459,100 1,459,100
2018-11-21 13G US16706W1027 / Chiasma Inc 1,459,100
2018-08-10 13G H03579101 / Auris Medical Holding Ltd 2,050,489
2018-05-15 13G/A PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock) 1,105,600 541,600
2018-02-14 13G/A TNXP / Tonix Pharmaceuticals Holding Corp. 594,077 594,077
2018-02-09 13G/A PSDV / pSivida Corp. 2,126,800 2,235,355
2018-02-09 13G/A ZSAN / Zosano Pharma Corp 2,083,100 32,500
2018-02-01 13G PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock) 1,105,600
2018-01-02 13G/A 76028H209 / Repros Therapeutics, Inc. 2,105,626 3,332,292
2017-07-24 13G 76028H209 / Repros Therapeutics, Inc. 2,105,626
2017-04-07 13G/A TNXP / Tonix Pharmaceuticals Holding Corp. 2,220,055 594,077
2017-04-07 13G PSDV / pSivida Corp. 2,126,800
2017-03-29 13G/A ZSAN / Zosano Pharma Corp 2,083,100 2,083,100
2017-03-28 13G/A ZSAN / Zosano Pharma Corp 2,023,777 2,083,100
2016-11-30 13G TNXP / Tonix Pharmaceuticals Holding Corp. 2,220,055
2016-11-16 13G ZSAN / Zosano Pharma Corp 2,023,777
2016-02-16 13G/A ALBO / Albireo Pharma Inc 3,592,889 590,590
2015-08-26 13G ALBO / Albireo Pharma Inc 2,883,313 3,592,889
2015-04-23 13G/A ALBO / Albireo Pharma Inc 2,883,313
2014-10-24 13G ALBO / Albireo Pharma Inc 1,265,492